Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076)
Clinical trial NCT01803607 · TERMINATED
Trial details
- NCT number
- NCT01803607
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-14
- Primary completion
- 2014-11-11
- Enrollment
- 135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.